Concepts (275)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trypanosoma cruzi | 31 | 2022 | 144 | 5.250 |
Why?
|
| Chagas Disease | 18 | 2022 | 96 | 3.390 |
Why?
|
| Protozoan Proteins | 10 | 2020 | 170 | 1.370 |
Why?
|
| Trypanocidal Agents | 6 | 2019 | 39 | 1.230 |
Why?
|
| Oxadiazoles | 3 | 2015 | 14 | 1.100 |
Why?
|
| Imidazoles | 5 | 2018 | 124 | 0.940 |
Why?
|
| Cytochrome P-450 Enzyme System | 6 | 2015 | 82 | 0.830 |
Why?
|
| Thrombospondin 1 | 4 | 2022 | 22 | 0.790 |
Why?
|
| alpha-Defensins | 2 | 2013 | 15 | 0.780 |
Why?
|
| Drug Discovery | 2 | 2019 | 77 | 0.690 |
Why?
|
| Antiprotozoal Agents | 3 | 2018 | 28 | 0.640 |
Why?
|
| RNA Interference | 3 | 2010 | 225 | 0.610 |
Why?
|
| Coronary Vessels | 2 | 2010 | 93 | 0.600 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2010 | 84 | 0.590 |
Why?
|
| RNA, Small Interfering | 3 | 2021 | 391 | 0.580 |
Why?
|
| Epithelial Cells | 3 | 2018 | 366 | 0.570 |
Why?
|
| Animals | 32 | 2022 | 14307 | 0.570 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2015 | 7 | 0.540 |
Why?
|
| Cocaine | 4 | 2020 | 219 | 0.530 |
Why?
|
| Benzamides | 2 | 2015 | 76 | 0.530 |
Why?
|
| Enzyme Inhibitors | 4 | 2013 | 396 | 0.500 |
Why?
|
| Host-Parasite Interactions | 3 | 2009 | 43 | 0.480 |
Why?
|
| Flagella | 1 | 2013 | 29 | 0.470 |
Why?
|
| Laminin | 2 | 2006 | 59 | 0.460 |
Why?
|
| Locomotion | 1 | 2013 | 91 | 0.450 |
Why?
|
| Defensins | 1 | 2010 | 5 | 0.390 |
Why?
|
| Humans | 36 | 2021 | 34853 | 0.390 |
Why?
|
| Gene Regulatory Networks | 2 | 2016 | 115 | 0.390 |
Why?
|
| Drug Design | 5 | 2018 | 154 | 0.380 |
Why?
|
| Casein Kinase II | 2 | 2008 | 15 | 0.370 |
Why?
|
| Trypanosoma brucei brucei | 4 | 2014 | 80 | 0.370 |
Why?
|
| MicroRNAs | 3 | 2020 | 386 | 0.370 |
Why?
|
| Mice | 15 | 2022 | 5668 | 0.350 |
Why?
|
| HIV-1 | 5 | 2020 | 678 | 0.330 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 135 | 0.330 |
Why?
|
| Endothelial Cells | 3 | 2022 | 296 | 0.330 |
Why?
|
| Aspergillus fumigatus | 2 | 2018 | 10 | 0.320 |
Why?
|
| Variant Surface Glycoproteins, Trypanosoma | 2 | 2014 | 8 | 0.320 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2019 | 160 | 0.310 |
Why?
|
| Galectin 3 | 2 | 2004 | 26 | 0.300 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 91 | 0.300 |
Why?
|
| Cloning, Molecular | 2 | 2012 | 310 | 0.300 |
Why?
|
| Myoblasts, Cardiac | 1 | 2006 | 4 | 0.290 |
Why?
|
| Mice, Inbred BALB C | 4 | 2015 | 649 | 0.290 |
Why?
|
| Cell Membrane | 4 | 2013 | 360 | 0.280 |
Why?
|
| Antifungal Agents | 4 | 2018 | 147 | 0.280 |
Why?
|
| Antigens, Protozoan | 2 | 2006 | 71 | 0.270 |
Why?
|
| Gene Silencing | 1 | 2006 | 143 | 0.260 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2017 | 75 | 0.260 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2022 | 54 | 0.260 |
Why?
|
| Ligands | 6 | 2021 | 317 | 0.260 |
Why?
|
| Mucins | 2 | 2002 | 33 | 0.260 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 127 | 0.240 |
Why?
|
| 3' Untranslated Regions | 2 | 2020 | 67 | 0.230 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 1300 | 0.230 |
Why?
|
| Membrane Proteins | 1 | 2006 | 486 | 0.220 |
Why?
|
| Naegleria fowleri | 1 | 2021 | 2 | 0.210 |
Why?
|
| Myocardium | 2 | 2020 | 224 | 0.210 |
Why?
|
| beta Catenin | 1 | 2022 | 46 | 0.210 |
Why?
|
| Substrate Specificity | 6 | 2021 | 186 | 0.210 |
Why?
|
| Rats | 5 | 2022 | 3261 | 0.200 |
Why?
|
| Proline | 1 | 2021 | 37 | 0.200 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2019 | 109 | 0.200 |
Why?
|
| Myoblasts | 1 | 2020 | 25 | 0.190 |
Why?
|
| Antigens, Differentiation | 1 | 2000 | 24 | 0.190 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2021 | 63 | 0.190 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2020 | 18 | 0.180 |
Why?
|
| Glutamic Acid | 1 | 2021 | 115 | 0.180 |
Why?
|
| Nucleus Accumbens | 1 | 2020 | 80 | 0.180 |
Why?
|
| Myocytes, Cardiac | 3 | 2020 | 165 | 0.180 |
Why?
|
| Capsid | 1 | 2020 | 51 | 0.180 |
Why?
|
| Molecular Structure | 4 | 2015 | 467 | 0.180 |
Why?
|
| Candida albicans | 2 | 2018 | 163 | 0.180 |
Why?
|
| Homeostasis | 1 | 2021 | 172 | 0.180 |
Why?
|
| Extracellular Matrix | 1 | 2000 | 111 | 0.180 |
Why?
|
| Triazoles | 4 | 2017 | 85 | 0.170 |
Why?
|
| Dipeptidases | 1 | 2019 | 5 | 0.170 |
Why?
|
| Nitroimidazoles | 1 | 2019 | 9 | 0.170 |
Why?
|
| Sterols | 4 | 2012 | 22 | 0.170 |
Why?
|
| Tetrazoles | 2 | 2017 | 49 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2019 | 63 | 0.170 |
Why?
|
| Microvessels | 1 | 2019 | 31 | 0.170 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 274 | 0.170 |
Why?
|
| Virus Release | 2 | 2016 | 7 | 0.170 |
Why?
|
| Methamphetamine | 1 | 2021 | 155 | 0.170 |
Why?
|
| Pyridines | 2 | 2017 | 113 | 0.170 |
Why?
|
| Protein Binding | 5 | 2017 | 913 | 0.160 |
Why?
|
| Colon | 1 | 2018 | 98 | 0.160 |
Why?
|
| Drugs, Investigational | 1 | 2017 | 1 | 0.160 |
Why?
|
| Amino Acid Sequence | 3 | 2010 | 1124 | 0.160 |
Why?
|
| Neuraminidase | 2 | 2008 | 8 | 0.150 |
Why?
|
| Phosphoproteins | 1 | 2018 | 154 | 0.150 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 153 | 0.150 |
Why?
|
| Cells, Cultured | 4 | 2018 | 1442 | 0.150 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 968 | 0.150 |
Why?
|
| Proteome | 1 | 2018 | 132 | 0.150 |
Why?
|
| Cell Adhesion | 3 | 2004 | 209 | 0.150 |
Why?
|
| Crystallography, X-Ray | 5 | 2018 | 237 | 0.150 |
Why?
|
| Protein Conformation | 5 | 2018 | 350 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2021 | 371 | 0.140 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2016 | 4 | 0.140 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2016 | 8 | 0.140 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2016 | 8 | 0.140 |
Why?
|
| Minority Groups | 1 | 2021 | 537 | 0.140 |
Why?
|
| Proline Oxidase | 1 | 2015 | 11 | 0.140 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 1490 | 0.130 |
Why?
|
| Antigens, CD | 1 | 2016 | 116 | 0.130 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2015 | 54 | 0.130 |
Why?
|
| Models, Molecular | 5 | 2018 | 751 | 0.130 |
Why?
|
| Biotransformation | 1 | 2015 | 65 | 0.130 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 81 | 0.130 |
Why?
|
| Ergosterol | 1 | 2014 | 10 | 0.130 |
Why?
|
| Microsomes, Liver | 1 | 2015 | 69 | 0.130 |
Why?
|
| Tissue Distribution | 1 | 2015 | 197 | 0.130 |
Why?
|
| Carbamates | 1 | 2014 | 11 | 0.130 |
Why?
|
| Adenoviridae | 1 | 2014 | 59 | 0.130 |
Why?
|
| Autophagy | 1 | 2015 | 111 | 0.120 |
Why?
|
| Genetic Vectors | 1 | 2014 | 154 | 0.120 |
Why?
|
| Capsid Proteins | 1 | 2014 | 60 | 0.120 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 376 | 0.120 |
Why?
|
| HCT116 Cells | 1 | 2013 | 34 | 0.120 |
Why?
|
| Molecular Weight | 2 | 2006 | 161 | 0.120 |
Why?
|
| HIV Infections | 2 | 2020 | 2207 | 0.120 |
Why?
|
| Cocaine-Related Disorders | 1 | 2014 | 84 | 0.120 |
Why?
|
| Adaptor Protein Complex 3 | 1 | 2012 | 1 | 0.110 |
Why?
|
| Adaptor Protein Complex delta Subunits | 1 | 2012 | 1 | 0.110 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 15 | 0.110 |
Why?
|
| Calreticulin | 1 | 2012 | 6 | 0.110 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2012 | 11 | 0.110 |
Why?
|
| Monocytes | 2 | 2019 | 258 | 0.110 |
Why?
|
| Neurons | 2 | 2021 | 1130 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2013 | 212 | 0.110 |
Why?
|
| Virus Assembly | 1 | 2012 | 38 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2015 | 490 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2013 | 322 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 251 | 0.110 |
Why?
|
| Hela Cells | 2 | 2016 | 344 | 0.100 |
Why?
|
| Mutation | 4 | 2020 | 1023 | 0.100 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 600 | 0.100 |
Why?
|
| Apoptosis | 2 | 2017 | 1317 | 0.090 |
Why?
|
| Brain | 1 | 2017 | 1268 | 0.090 |
Why?
|
| Trypanosomiasis, African | 1 | 2009 | 23 | 0.090 |
Why?
|
| Immunoprecipitation | 2 | 2012 | 126 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2013 | 469 | 0.090 |
Why?
|
| Indomethacin | 1 | 2009 | 24 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 2 | 2002 | 282 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 298 | 0.090 |
Why?
|
| Phagocytosis | 1 | 1989 | 64 | 0.090 |
Why?
|
| Trypanosoma | 1 | 2008 | 8 | 0.090 |
Why?
|
| Fibronectins | 1 | 1989 | 65 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2013 | 1349 | 0.080 |
Why?
|
| Amides | 1 | 2009 | 66 | 0.080 |
Why?
|
| Binding Sites | 2 | 2020 | 597 | 0.080 |
Why?
|
| Female | 4 | 2015 | 19873 | 0.080 |
Why?
|
| Nuclear Localization Signals | 1 | 2008 | 14 | 0.080 |
Why?
|
| Serine Endopeptidases | 1 | 2008 | 36 | 0.080 |
Why?
|
| Cysteine Endopeptidases | 1 | 2008 | 57 | 0.080 |
Why?
|
| Trypanosomiasis | 1 | 2007 | 1 | 0.080 |
Why?
|
| Response Elements | 1 | 2008 | 52 | 0.080 |
Why?
|
| Vacuoles | 1 | 2007 | 22 | 0.080 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 34 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2008 | 100 | 0.080 |
Why?
|
| Macrophages | 2 | 2003 | 431 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 164 | 0.080 |
Why?
|
| Oxidoreductases | 1 | 2007 | 82 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 550 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 2128 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2007 | 135 | 0.070 |
Why?
|
| Immunoblotting | 2 | 2010 | 170 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 143 | 0.070 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2008 | 73 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2020 | 1802 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 1530 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2008 | 351 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2006 | 878 | 0.070 |
Why?
|
| Virulence Factors | 1 | 2006 | 113 | 0.070 |
Why?
|
| Microsomes | 2 | 2018 | 52 | 0.070 |
Why?
|
| Catalytic Domain | 2 | 2018 | 97 | 0.060 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2003 | 16 | 0.060 |
Why?
|
| Transfection | 1 | 2004 | 496 | 0.060 |
Why?
|
| Male | 5 | 2021 | 18870 | 0.060 |
Why?
|
| Methyltransferases | 2 | 2014 | 56 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2017 | 203 | 0.060 |
Why?
|
| Immunoglobulin Fragments | 1 | 2002 | 7 | 0.050 |
Why?
|
| Hybridomas | 1 | 2002 | 28 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2008 | 874 | 0.050 |
Why?
|
| Endothelium | 1 | 2022 | 31 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 195 | 0.050 |
Why?
|
| Epitopes | 1 | 2002 | 145 | 0.050 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2021 | 14 | 0.050 |
Why?
|
| Maryland | 1 | 2021 | 53 | 0.050 |
Why?
|
| Cricetulus | 1 | 2021 | 74 | 0.050 |
Why?
|
| Cell Line | 1 | 2004 | 1289 | 0.050 |
Why?
|
| CHO Cells | 1 | 2021 | 107 | 0.050 |
Why?
|
| Acute Disease | 1 | 2021 | 141 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 58 | 0.050 |
Why?
|
| Communicable Diseases | 1 | 2021 | 42 | 0.050 |
Why?
|
| Lactose | 1 | 2000 | 13 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 46 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2000 | 51 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 445 | 0.050 |
Why?
|
| Heart | 1 | 2022 | 178 | 0.050 |
Why?
|
| Cross Reactions | 1 | 2000 | 83 | 0.050 |
Why?
|
| Models, Animal | 1 | 2020 | 131 | 0.050 |
Why?
|
| Virus Integration | 1 | 2020 | 49 | 0.050 |
Why?
|
| Azoles | 2 | 2011 | 13 | 0.050 |
Why?
|
| Research Personnel | 1 | 2021 | 133 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 161 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2020 | 167 | 0.040 |
Why?
|
| Collagen | 1 | 2000 | 162 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2022 | 897 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2019 | 91 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 984 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 180 | 0.040 |
Why?
|
| Drug Stability | 1 | 2018 | 110 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2019 | 171 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 217 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 420 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 220 | 0.040 |
Why?
|
| Annexin A5 | 1 | 2017 | 24 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2000 | 834 | 0.040 |
Why?
|
| Ketoconazole | 1 | 2017 | 7 | 0.040 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2017 | 45 | 0.040 |
Why?
|
| Fluconazole | 1 | 2017 | 41 | 0.040 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2017 | 72 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 522 | 0.040 |
Why?
|
| Neuroblastoma | 1 | 2017 | 128 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2017 | 423 | 0.040 |
Why?
|
| Proteomics | 1 | 2018 | 302 | 0.040 |
Why?
|
| Cattle | 1 | 2017 | 472 | 0.030 |
Why?
|
| Heme | 1 | 2015 | 69 | 0.030 |
Why?
|
| Fibrosis | 1 | 2016 | 146 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 642 | 0.030 |
Why?
|
| Itraconazole | 1 | 2014 | 12 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 628 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 407 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2014 | 162 | 0.030 |
Why?
|
| Virion | 1 | 2014 | 67 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 91 | 0.030 |
Why?
|
| Cholesterol | 1 | 2014 | 194 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 416 | 0.030 |
Why?
|
| Tropical Medicine | 1 | 2012 | 7 | 0.030 |
Why?
|
| Clathrin | 1 | 2012 | 19 | 0.030 |
Why?
|
| RNA | 1 | 2014 | 234 | 0.030 |
Why?
|
| Life Cycle Stages | 1 | 2012 | 27 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2014 | 392 | 0.030 |
Why?
|
| Cytokines | 1 | 2016 | 569 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2012 | 100 | 0.030 |
Why?
|
| Metabolome | 1 | 2012 | 47 | 0.030 |
Why?
|
| Mitochondria | 1 | 2015 | 454 | 0.030 |
Why?
|
| Endocytosis | 1 | 2012 | 104 | 0.030 |
Why?
|
| Disease Progression | 1 | 2014 | 580 | 0.030 |
Why?
|
| Skin | 1 | 2012 | 173 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 1033 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2012 | 252 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 485 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2009 | 27 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 172 | 0.020 |
Why?
|
| Antiparasitic Agents | 1 | 2009 | 8 | 0.020 |
Why?
|
| Receptors, Fibronectin | 1 | 1989 | 3 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2009 | 35 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2009 | 33 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1989 | 117 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2012 | 436 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1989 | 59 | 0.020 |
Why?
|
| alpha Karyopherins | 1 | 2008 | 3 | 0.020 |
Why?
|
| beta Karyopherins | 1 | 2008 | 4 | 0.020 |
Why?
|
| Hydroquinones | 1 | 2008 | 8 | 0.020 |
Why?
|
| K562 Cells | 1 | 2008 | 31 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 85 | 0.020 |
Why?
|
| Peptides | 1 | 2008 | 308 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 63 | 0.010 |
Why?
|
| Tyrosine | 1 | 2003 | 109 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 296 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 549 | 0.010 |
Why?
|